SG Americas Securities’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
Other funds holding MCRB
FP
TCM
SG Americas Securities's MCRB Position: Q2 2024 in Review
SG Americas Securities sold out of Seres Therapeutics (MCRB) in Q2 2024, closing a stake of 519 shares — an estimated $8K sold.
SG Americas Securities first reported a position in MCRB in Q2 2019 and held it in 12 quarters. The position peaked at $3.69M in Q3 2021. 93 funds tracked by Wall St. Rank hold MCRB as of Q2 2024.
- SG Americas Securities reported no remaining Seres Therapeutics position as of Q2 2024 after selling out during the quarter.
- SG Americas Securities sold 519 Seres Therapeutics shares in Q2 2024, an estimated $8K.
- SG Americas Securities first reported a position in Seres Therapeutics in Q2 2019 and held it in 12 quarters.
- SG Americas Securities's Seres Therapeutics position peaked at $3.69M in Q3 2021.
- 93 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2024.
Based on SG Americas Securities's 13F filing for Q2 2024, filed 12 Jul 2024.